Fairmount Funds Management LLC, a director at Cogent Biosciences, Inc. (COGT), executed a significant sale of company shares on March 31, 2026. The transaction involved 7,000,000 shares sold at an average price of $34.66 per share, amounting to approximately $242.62 million.
This follows another substantial sale by Fairmount Funds Management LLC earlier in the year, on January 22, 2026, when 3,500,000 shares were sold for roughly $127.4 million. Insider sales can occur for a variety of reasons, including portfolio diversification, tax planning, or adherence to pre-arranged trading strategies, and do not inherently signal a negative view of the company's prospects.